Global SWFI for Reconstitution of Lyophilized Drugs Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global SWFI for Reconstitution of Lyophilized Drugs Market
Sterile Water for Injection (SWFI) is sterile, nonpyrogenic, distilled water in a single dose container for intravenous administration after addition of a suitable solute. It may also be used as a dispensing container for diluent use.

SWFI are used for reconstitution of lyophilized drugs, diluent of injection solution and rinsing agent for endoscopy in various departments. SWFI for reconstitution of lyophilized drugs.

In this report, we only collect data of SWFI being sold as a part of set with LYO drug.

Due to the COVID-19 pandemic, the global SWFI for Reconstitution of Lyophilized Drugs market size is estimated to be worth US$ 14 million in 2022 and is forecast to a readjusted size of US$ 19 million by 2028 with a CAGR of 5.4% during the review period. Fully considering the economic change by this health crisis, Vials and Ampoules accounting for % of the SWFI for Reconstitution of Lyophilized Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Vaccine segment is altered to an % CAGR throughout this forecast period.

Asia-Pacific and Europe are the two largest consumption regions, with a consumption market share nearly 40% and 30%. North America is also an important sales region.

Market competition is intense. Baxter, Hospira (ICU Medical), Vetter, Otsuka, ROVI, Fresenius Kabi, etc. are the leaders of the industry, they hold key technologies and patents, with high-end customers.

The classification of SWFI for reconstitution of lyophilized drugs includes Vials and Ampoules and Pre-Filled Syringes. The sales proportion of Vials and Ampoules is over 95%.

SWFI for reconstitution of lyophilized drugs is widely used for vaccines, Biological Products, Bio-pharmaceutical. The most proportion of SWFI for reconstitution of lyophilized drugs is used for vaccine, the proportion is about 73%.

Market Segments

The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.

Segment by Container

Vials and Ampoules

Pre-Filled Syringes

Segment by Application

Vaccine

Biological Products

Bio-Pharmaceutical

Consequence of Covid-19 Pandemic

The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the SWFI for Reconstitution of Lyophilized Drugs market back to the pre-covid levels.

Trends & Prospects

In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.

By Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Outlook

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

Baxter

Hospira (ICU Medical)

Vetter

Otsuka

ROVI

Fresenius Kabi

Shijiazhuang No. 4 Pharmaceutical

Hikma

Kelun

Deo Gratias Parenteral

TABLE OF CONTENT

1 Study Coverage
1.1 SWFI for Reconstitution of Lyophilized Drugs Product Introduction

1.2 Market by Container

1.2.1 Global SWFI for Reconstitution of Lyophilized Drugs Market Size Growth Rate by Container, 2017 VS 2021 VS 2028

1.2.2 Vials and Ampoules

1.2.3 Pre-Filled Syringes

1.3 Market by Application

1.3.1 Global SWFI for Reconstitution of Lyophilized Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Vaccine

1.3.3 Biological Products

1.3.4 Bio-Pharmaceutical

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global SWFI for Reconstitution of Lyophilized Drugs Sales Estimates and Forecasts 2017-2028

2.2 Global SWFI for Reconstitution of Lyophilized Drugs Revenue Estimates and Forecasts 2017-2028

2.3 Global SWFI for Reconstitution of Lyophilized Drugs Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global SWFI for Reconstitution of Lyophilized Drugs Sales by Region

2.4.1 Global SWFI for Reconstitution of Lyophilized Drugs Sales by Region (2017-2022)

2.4.2 Global Sales SWFI for Reconstitution of Lyophilized Drugs by Region (2023-2028)

2.5 Global SWFI for Reconstitution of Lyophilized Drugs Revenue by Region

2.5.1 Global SWFI for Reconstitution of Lyophilized Drugs Revenue by Region (2017-2022)

2.5.2 Global SWFI for Reconstitution of Lyophilized Drugs Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global SWFI for Reconstitution of Lyophilized Drugs Sales by Manufacturers

3.1.1 Global Top SWFI for Reconstitution of Lyophilized Drugs Manufacturers by Sales (2017-2022)

3.1.2 Global SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of SWFI for Reconstitution of Lyophilized Drugs in 2021

3.2 Global SWFI for Reconstitution of Lyophilized Drugs Revenue by Manufacturers

3.2.1 Global SWFI for Reconstitution of Lyophilized Drugs Revenue by Manufacturers (2017-2022)

3.2.2 Global SWFI for Reconstitution of Lyophilized Drugs Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by SWFI for Reconstitution of Lyophilized Drugs Revenue in 2021

3.3 Global SWFI for Reconstitution of Lyophilized Drugs Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global SWFI for Reconstitution of Lyophilized Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global SWFI for Reconstitution of Lyophilized Drugs Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Container

4.1 Global SWFI for Reconstitution of Lyophilized Drugs Sales by Container

4.1.1 Global SWFI for Reconstitution of Lyophilized Drugs Historical Sales by Container (2017-2022)

4.1.2 Global SWFI for Reconstitution of Lyophilized Drugs Forecasted Sales by Container (2023-2028)

4.1.3 Global SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Container (2017-2028)

4.2 Global SWFI for Reconstitution of Lyophilized Drugs Revenue by Container

4.2.1 Global SWFI for Reconstitution of Lyophilized Drugs Historical Revenue by Container (2017-2022)

4.2.2 Global SWFI for Reconstitution of Lyophilized Drugs Forecasted Revenue by Container (2023-2028)

4.2.3 Global SWFI for Reconstitution of Lyophilized Drugs Revenue Market Share by Container (2017-2028)

4.3 Global SWFI for Reconstitution of Lyophilized Drugs Price by Container

4.3.1 Global SWFI for Reconstitution of Lyophilized Drugs Price by Container (2017-2022)

4.3.2 Global SWFI for Reconstitution of Lyophilized Drugs Price Forecast by Container (2023-2028)

5 Market Size by Application

5.1 Global SWFI for Reconstitution of Lyophilized Drugs Sales by Application

5.1.1 Global SWFI for Reconstitution of Lyophilized Drugs Historical Sales by Application (2017-2022)

5.1.2 Global SWFI for Reconstitution of Lyophilized Drugs Forecasted Sales by Application (2023-2028)

5.1.3 Global SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Application (2017-2028)

5.2 Global SWFI for Reconstitution of Lyophilized Drugs Revenue by Application

5.2.1 Global SWFI for Reconstitution of Lyophilized Drugs Historical Revenue by Application (2017-2022)

5.2.2 Global SWFI for Reconstitution of Lyophilized Drugs Forecasted Revenue by Application (2023-2028)

5.2.3 Global SWFI for Reconstitution of Lyophilized Drugs Revenue Market Share by Application (2017-2028)

5.3 Global SWFI for Reconstitution of Lyophilized Drugs Price by Application

5.3.1 Global SWFI for Reconstitution of Lyophilized Drugs Price by Application (2017-2022)

5.3.2 Global SWFI for Reconstitution of Lyophilized Drugs Price Forecast by Application (2023-2028)

6 North America

6.1 North America SWFI for Reconstitution of Lyophilized Drugs Market Size by Container

6.1.1 North America SWFI for Reconstitution of Lyophilized Drugs Sales by Container (2017-2028)

6.1.2 North America SWFI for Reconstitution of Lyophilized Drugs Revenue by Container (2017-2028)

6.2 North America SWFI for Reconstitution of Lyophilized Drugs Market Size by Application

6.2.1 North America SWFI for Reconstitution of Lyophilized Drugs Sales by Application (2017-2028)

6.2.2 North America SWFI for Reconstitution of Lyophilized Drugs Revenue by Application (2017-2028)

6.3 North America SWFI for Reconstitution of Lyophilized Drugs Market Size by Country

6.3.1 North America SWFI for Reconstitution of Lyophilized Drugs Sales by Country (2017-2028)

6.3.2 North America SWFI for Reconstitution of Lyophilized Drugs Revenue by Country (2017-2028)

6.3.3 United States

6.3.4 Canada

7 Europe

7.1 Europe SWFI for Reconstitution of Lyophilized Drugs Market Size by Container

7.1.1 Europe SWFI for Reconstitution of Lyophilized Drugs Sales by Container (2017-2028)

7.1.2 Europe SWFI for Reconstitution of Lyophilized Drugs Revenue by Container (2017-2028)

7.2 Europe SWFI for Reconstitution of Lyophilized Drugs Market Size by Application

7.2.1 Europe SWFI for Reconstitution of Lyophilized Drugs Sales by Application (2017-2028)

7.2.2 Europe SWFI for Reconstitution of Lyophilized Drugs Revenue by Application (2017-2028)

7.3 Europe SWFI for Reconstitution of Lyophilized Drugs Market Size by Country

7.3.1 Europe SWFI for Reconstitution of Lyophilized Drugs Sales by Country (2017-2028)

7.3.2 Europe SWFI for Reconstitution of Lyophilized Drugs Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific SWFI for Reconstitution of Lyophilized Drugs Market Size by Container

8.1.1 Asia Pacific SWFI for Reconstitution of Lyophilized Drugs Sales by Container (2017-2028)

8.1.2 Asia Pacific SWFI for Reconstitution of Lyophilized Drugs Revenue by Container (2017-2028)

8.2 Asia Pacific SWFI for Reconstitution of Lyophilized Drugs Market Size by Application

8.2.1 Asia Pacific SWFI for Reconstitution of Lyophilized Drugs Sales by Application (2017-2028)

8.2.2 Asia Pacific SWFI for Reconstitution of Lyophilized Drugs Revenue by Application (2017-2028)

8.3 Asia Pacific SWFI for Reconstitution of Lyophilized Drugs Market Size by Region

8.3.1 Asia Pacific SWFI for Reconstitution of Lyophilized Drugs Sales by Region (2017-2028)

8.3.2 Asia Pacific SWFI for Reconstitution of Lyophilized Drugs Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 China Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

9 Latin America

9.1 Latin America SWFI for Reconstitution of Lyophilized Drugs Market Size by Container

9.1.1 Latin America SWFI for Reconstitution of Lyophilized Drugs Sales by Container (2017-2028)

9.1.2 Latin America SWFI for Reconstitution of Lyophilized Drugs Revenue by Container (2017-2028)

9.2 Latin America SWFI for Reconstitution of Lyophilized Drugs Market Size by Application

9.2.1 Latin America SWFI for Reconstitution of Lyophilized Drugs Sales by Application (2017-2028)

9.2.2 Latin America SWFI for Reconstitution of Lyophilized Drugs Revenue by Application (2017-2028)

9.3 Latin America SWFI for Reconstitution of Lyophilized Drugs Market Size by Country

9.3.1 Latin America SWFI for Reconstitution of Lyophilized Drugs Sales by Country (2017-2028)

9.3.2 Latin America SWFI for Reconstitution of Lyophilized Drugs Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa SWFI for Reconstitution of Lyophilized Drugs Market Size by Container

10.1.1 Middle East and Africa SWFI for Reconstitution of Lyophilized Drugs Sales by Container (2017-2028)

10.1.2 Middle East and Africa SWFI for Reconstitution of Lyophilized Drugs Revenue by Container (2017-2028)

10.2 Middle East and Africa SWFI for Reconstitution of Lyophilized Drugs Market Size by Application

10.2.1 Middle East and Africa SWFI for Reconstitution of Lyophilized Drugs Sales by Application (2017-2028)

10.2.2 Middle East and Africa SWFI for Reconstitution of Lyophilized Drugs Revenue by Application (2017-2028)

10.3 Middle East and Africa SWFI for Reconstitution of Lyophilized Drugs Market Size by Country

10.3.1 Middle East and Africa SWFI for Reconstitution of Lyophilized Drugs Sales by Country (2017-2028)

10.3.2 Middle East and Africa SWFI for Reconstitution of Lyophilized Drugs Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 Baxter

11.1.1 Baxter Corporation Information

11.1.2 Baxter Overview

11.1.3 Baxter SWFI for Reconstitution of Lyophilized Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 Baxter SWFI for Reconstitution of Lyophilized Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Baxter Recent Developments

11.2 Hospira (ICU Medical)

11.2.1 Hospira (ICU Medical) Corporation Information

11.2.2 Hospira (ICU Medical) Overview

11.2.3 Hospira (ICU Medical) SWFI for Reconstitution of Lyophilized Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Hospira (ICU Medical) SWFI for Reconstitution of Lyophilized Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Hospira (ICU Medical) Recent Developments

11.3 Vetter

11.3.1 Vetter Corporation Information

11.3.2 Vetter Overview

11.3.3 Vetter SWFI for Reconstitution of Lyophilized Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Vetter SWFI for Reconstitution of Lyophilized Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Vetter Recent Developments

11.4 Otsuka

11.4.1 Otsuka Corporation Information

11.4.2 Otsuka Overview

11.4.3 Otsuka SWFI for Reconstitution of Lyophilized Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Otsuka SWFI for Reconstitution of Lyophilized Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Otsuka Recent Developments

11.5 ROVI

11.5.1 ROVI Corporation Information

11.5.2 ROVI Overview

11.5.3 ROVI SWFI for Reconstitution of Lyophilized Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 ROVI SWFI for Reconstitution of Lyophilized Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 ROVI Recent Developments

11.6 Fresenius Kabi

11.6.1 Fresenius Kabi Corporation Information

11.6.2 Fresenius Kabi Overview

11.6.3 Fresenius Kabi SWFI for Reconstitution of Lyophilized Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 Fresenius Kabi SWFI for Reconstitution of Lyophilized Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Fresenius Kabi Recent Developments

11.7 Shijiazhuang No. 4 Pharmaceutical

11.7.1 Shijiazhuang No. 4 Pharmaceutical Corporation Information

11.7.2 Shijiazhuang No. 4 Pharmaceutical Overview

11.7.3 Shijiazhuang No. 4 Pharmaceutical SWFI for Reconstitution of Lyophilized Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 Shijiazhuang No. 4 Pharmaceutical SWFI for Reconstitution of Lyophilized Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Shijiazhuang No. 4 Pharmaceutical Recent Developments

11.8 Hikma

11.8.1 Hikma Corporation Information

11.8.2 Hikma Overview

11.8.3 Hikma SWFI for Reconstitution of Lyophilized Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.8.4 Hikma SWFI for Reconstitution of Lyophilized Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Hikma Recent Developments

11.9 Kelun

11.9.1 Kelun Corporation Information

11.9.2 Kelun Overview

11.9.3 Kelun SWFI for Reconstitution of Lyophilized Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.9.4 Kelun SWFI for Reconstitution of Lyophilized Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Kelun Recent Developments

11.10 Deo Gratias Parenteral

11.10.1 Deo Gratias Parenteral Corporation Information

11.10.2 Deo Gratias Parenteral Overview

11.10.3 Deo Gratias Parenteral SWFI for Reconstitution of Lyophilized Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.10.4 Deo Gratias Parenteral SWFI for Reconstitution of Lyophilized Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Deo Gratias Parenteral Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 SWFI for Reconstitution of Lyophilized Drugs Industry Chain Analysis

12.2 SWFI for Reconstitution of Lyophilized Drugs Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 SWFI for Reconstitution of Lyophilized Drugs Production Mode & Process

12.4 SWFI for Reconstitution of Lyophilized Drugs Sales and Marketing

12.4.1 SWFI for Reconstitution of Lyophilized Drugs Sales Channels

12.4.2 SWFI for Reconstitution of Lyophilized Drugs Distributors

12.5 SWFI for Reconstitution of Lyophilized Drugs Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 SWFI for Reconstitution of Lyophilized Drugs Industry Trends

13.2 SWFI for Reconstitution of Lyophilized Drugs Market Drivers

13.3 SWFI for Reconstitution of Lyophilized Drugs Market Challenges

13.4 SWFI for Reconstitution of Lyophilized Drugs Market Restraints

14 Key Findings in The Global SWFI for Reconstitution of Lyophilized Drugs Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

Choose License Type

Checkout Inquiry Sample